Mark Thornton

Mark Thornton is a Senior Clinical Consultant at Biologics Consulting Group, Inc. since January 2013, specializing in oncology product development for a global clientele. Mark possesses expertise in clinical trial design and analysis, coupled with regulatory strategic acumen, with experience at the FDA and in the industry focusing on gene, viral, cell, antibody therapies, and immunotherapies. Prior to this role, Mark served as President of Thornton BioPharm Consulting, LLC from 2012 to January 2013, leveraging over 20 years of FDA and biotech/pharmaceutical experience to enhance drug development processes, particularly in clinical development strategy and trial design.